Vitamin D is a likely candidate for treatment as its immune modulating characteristics have effects on coronavirus disease 2019 (COVID-19) patients. It was sought herein, to summarize the studies published to date regarding the vitamin D supplementation to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive patients.

Matéria original

Anterior

Potent and Selective Covalent Inhibitors of the Papain-like Protease from SARS-CoV-2

Próxima

Evento debate estímulo a IFAs vegetais e produtos da biodiversidade

Evento debate estímulo a IFAs vegetais e produtos da biodiversidade